HLA-A Kit ELISA
-
- Antigène Voir toutes HLA-A Kits ELISA
- HLA-A (Major Histocompatibility Complex, Class I, A (HLA-A))
-
Reactivité
- Humain
- Méthode de détection
- Colorimetric
- Type de méthode
- Sandwich ELISA
- Gamme de detection
- 0.31-20 ng/mL
- Seuil minimal de détection
- 0.31 ng/mL
- Application
- ELISA
- Marque
- BioAssay™
- Sensibilité
- < 0.126 ng/mL
- Featured
- Discover our best selling HLA-A Kit ELISA
- Top Product
- Discover our top product HLA-A Kit ELISA
-
-
- Plaque
- Pre-coated
- Protocole
- Major Histocompatibility Complex Class I A (MHCA) BioAssay-ELISA Kit (Human) is a Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Major Histocompatibility Complex Class I A (MHCA). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Major Histocompatibility Complex Class I A (MHCA). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Major Histocompatibility Complex Class I A (MHCA), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm±10nm. The concentration of Major Histocompatibility Complex Class I A (MHCA) in the samples is then determined by comparing the O.D. of the samples to the standard curve.
- Restrictions
- For Research Use only
-
- Stock
- 4 °C/-20 °C
-
- Antigène Voir toutes HLA-A Kits ELISA
- HLA-A (Major Histocompatibility Complex, Class I, A (HLA-A))
- Autre désignation
- Major Histocompatibility Complex Class I A (MHCA) (HLA-A Produits)
- Synonymes
- HLAA Kit ELISA, major histocompatibility complex, class I, A Kit ELISA, HLA-A Kit ELISA
- Pathways
- TCR Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
-